nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Linezolid—Skin disorder—Gemcitabine—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Linezolid—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Linezolid—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Linezolid—Dizziness—Tamoxifen—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Linezolid—Anorexia—Gemcitabine—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Linezolid—Dizziness—Erlotinib—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Linezolid—Erythema multiforme—Docetaxel—pancreatic cancer	0.001	0.001	CcSEcCtD
Linezolid—Anorexia—Fluorouracil—pancreatic cancer	0.000996	0.000996	CcSEcCtD
Linezolid—Insomnia—Irinotecan—pancreatic cancer	0.000987	0.000987	CcSEcCtD
Linezolid—Vomiting—Tamoxifen—pancreatic cancer	0.000983	0.000983	CcSEcCtD
Linezolid—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000981	0.000981	CcSEcCtD
Linezolid—Paraesthesia—Irinotecan—pancreatic cancer	0.00098	0.00098	CcSEcCtD
Linezolid—Rash—Tamoxifen—pancreatic cancer	0.000975	0.000975	CcSEcCtD
Linezolid—Dermatitis—Tamoxifen—pancreatic cancer	0.000974	0.000974	CcSEcCtD
Linezolid—Vomiting—Erlotinib—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Linezolid—Dyspnoea—Irinotecan—pancreatic cancer	0.000973	0.000973	CcSEcCtD
Linezolid—Somnolence—Irinotecan—pancreatic cancer	0.00097	0.00097	CcSEcCtD
Linezolid—Headache—Tamoxifen—pancreatic cancer	0.000969	0.000969	CcSEcCtD
Linezolid—Rash—Erlotinib—pancreatic cancer	0.000965	0.000965	CcSEcCtD
Linezolid—Dermatitis—Erlotinib—pancreatic cancer	0.000964	0.000964	CcSEcCtD
Linezolid—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000962	0.000962	CcSEcCtD
Linezolid—Insomnia—Gemcitabine—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Linezolid—Dyspepsia—Irinotecan—pancreatic cancer	0.000961	0.000961	CcSEcCtD
Linezolid—Headache—Erlotinib—pancreatic cancer	0.000959	0.000959	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000958	0.000958	CcSEcCtD
Linezolid—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000956	0.000956	CcSEcCtD
Linezolid—Paraesthesia—Gemcitabine—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Linezolid—Chills—Docetaxel—pancreatic cancer	0.000953	0.000953	CcSEcCtD
Linezolid—Asthenia—Sunitinib—pancreatic cancer	0.00095	0.00095	CcSEcCtD
Linezolid—Decreased appetite—Irinotecan—pancreatic cancer	0.000949	0.000949	CcSEcCtD
Linezolid—Dyspnoea—Gemcitabine—pancreatic cancer	0.000948	0.000948	CcSEcCtD
Linezolid—Insomnia—Fluorouracil—pancreatic cancer	0.000945	0.000945	CcSEcCtD
Linezolid—Somnolence—Gemcitabine—pancreatic cancer	0.000945	0.000945	CcSEcCtD
Linezolid—Hypokalaemia—Epirubicin—pancreatic cancer	0.000942	0.000942	CcSEcCtD
Linezolid—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000942	0.000942	CcSEcCtD
Linezolid—Fatigue—Irinotecan—pancreatic cancer	0.000941	0.000941	CcSEcCtD
Linezolid—Paraesthesia—Fluorouracil—pancreatic cancer	0.000938	0.000938	CcSEcCtD
Linezolid—Pruritus—Sunitinib—pancreatic cancer	0.000937	0.000937	CcSEcCtD
Linezolid—Pain—Irinotecan—pancreatic cancer	0.000933	0.000933	CcSEcCtD
Linezolid—Constipation—Irinotecan—pancreatic cancer	0.000933	0.000933	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000932	0.000932	CcSEcCtD
Linezolid—Dyspnoea—Fluorouracil—pancreatic cancer	0.000932	0.000932	CcSEcCtD
Linezolid—Somnolence—Fluorouracil—pancreatic cancer	0.000929	0.000929	CcSEcCtD
Linezolid—Erythema—Docetaxel—pancreatic cancer	0.000924	0.000924	CcSEcCtD
Linezolid—Decreased appetite—Gemcitabine—pancreatic cancer	0.000924	0.000924	CcSEcCtD
Linezolid—Dyspepsia—Fluorouracil—pancreatic cancer	0.00092	0.00092	CcSEcCtD
Linezolid—Nausea—Tamoxifen—pancreatic cancer	0.000919	0.000919	CcSEcCtD
Linezolid—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000918	0.000918	CcSEcCtD
Linezolid—Fatigue—Gemcitabine—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Linezolid—Gastritis—Epirubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000913	0.000913	CcSEcCtD
Linezolid—Pain—Gemcitabine—pancreatic cancer	0.000909	0.000909	CcSEcCtD
Linezolid—Constipation—Gemcitabine—pancreatic cancer	0.000909	0.000909	CcSEcCtD
Linezolid—Nausea—Erlotinib—pancreatic cancer	0.000909	0.000909	CcSEcCtD
Linezolid—Decreased appetite—Fluorouracil—pancreatic cancer	0.000909	0.000909	CcSEcCtD
Linezolid—Diarrhoea—Sunitinib—pancreatic cancer	0.000906	0.000906	CcSEcCtD
Linezolid—Dysgeusia—Docetaxel—pancreatic cancer	0.000905	0.000905	CcSEcCtD
Linezolid—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000902	0.000902	CcSEcCtD
Linezolid—Pain—Fluorouracil—pancreatic cancer	0.000894	0.000894	CcSEcCtD
Linezolid—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000892	0.000892	CcSEcCtD
Linezolid—Muscle spasms—Docetaxel—pancreatic cancer	0.000889	0.000889	CcSEcCtD
Linezolid—Eosinophilia—Epirubicin—pancreatic cancer	0.000886	0.000886	CcSEcCtD
Linezolid—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000884	0.000884	CcSEcCtD
Linezolid—Pancreatitis—Epirubicin—pancreatic cancer	0.000877	0.000877	CcSEcCtD
Linezolid—Dizziness—Sunitinib—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Linezolid—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000872	0.000872	CcSEcCtD
Linezolid—Abdominal pain—Irinotecan—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Linezolid—Body temperature increased—Irinotecan—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000863	0.000863	CcSEcCtD
Linezolid—Anaemia—Docetaxel—pancreatic cancer	0.000854	0.000854	CcSEcCtD
Linezolid—Pancytopenia—Epirubicin—pancreatic cancer	0.00085	0.00085	CcSEcCtD
Linezolid—Gastritis—Doxorubicin—pancreatic cancer	0.000848	0.000848	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000845	0.000845	CcSEcCtD
Linezolid—Vomiting—Sunitinib—pancreatic cancer	0.000842	0.000842	CcSEcCtD
Linezolid—Body temperature increased—Gemcitabine—pancreatic cancer	0.00084	0.00084	CcSEcCtD
Linezolid—Neutropenia—Epirubicin—pancreatic cancer	0.000837	0.000837	CcSEcCtD
Linezolid—Rash—Sunitinib—pancreatic cancer	0.000835	0.000835	CcSEcCtD
Linezolid—Dermatitis—Sunitinib—pancreatic cancer	0.000834	0.000834	CcSEcCtD
Linezolid—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000832	0.000832	CcSEcCtD
Linezolid—Urticaria—Fluorouracil—pancreatic cancer	0.00083	0.00083	CcSEcCtD
Linezolid—Headache—Sunitinib—pancreatic cancer	0.00083	0.00083	CcSEcCtD
Linezolid—Leukopenia—Docetaxel—pancreatic cancer	0.000827	0.000827	CcSEcCtD
Linezolid—Body temperature increased—Fluorouracil—pancreatic cancer	0.000826	0.000826	CcSEcCtD
Linezolid—Eosinophilia—Doxorubicin—pancreatic cancer	0.00082	0.00082	CcSEcCtD
Linezolid—Pancreatitis—Doxorubicin—pancreatic cancer	0.000812	0.000812	CcSEcCtD
Linezolid—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Linezolid—Cough—Docetaxel—pancreatic cancer	0.000807	0.000807	CcSEcCtD
Linezolid—Pneumonia—Epirubicin—pancreatic cancer	0.000802	0.000802	CcSEcCtD
Linezolid—Convulsion—Docetaxel—pancreatic cancer	0.000801	0.000801	CcSEcCtD
Linezolid—Hypertension—Docetaxel—pancreatic cancer	0.000798	0.000798	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000791	0.000791	CcSEcCtD
Linezolid—Nausea—Sunitinib—pancreatic cancer	0.000787	0.000787	CcSEcCtD
Linezolid—Pancytopenia—Doxorubicin—pancreatic cancer	0.000786	0.000786	CcSEcCtD
Linezolid—Renal failure—Epirubicin—pancreatic cancer	0.000784	0.000784	CcSEcCtD
Linezolid—Asthenia—Irinotecan—pancreatic cancer	0.000783	0.000783	CcSEcCtD
Linezolid—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000782	0.000782	CcSEcCtD
Linezolid—Stomatitis—Epirubicin—pancreatic cancer	0.000778	0.000778	CcSEcCtD
Linezolid—Neutropenia—Doxorubicin—pancreatic cancer	0.000774	0.000774	CcSEcCtD
Linezolid—Dry mouth—Docetaxel—pancreatic cancer	0.00077	0.00077	CcSEcCtD
Linezolid—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Linezolid—Asthenia—Gemcitabine—pancreatic cancer	0.000763	0.000763	CcSEcCtD
Linezolid—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000754	0.000754	CcSEcCtD
Linezolid—Pruritus—Gemcitabine—pancreatic cancer	0.000752	0.000752	CcSEcCtD
Linezolid—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Linezolid—Diarrhoea—Irinotecan—pancreatic cancer	0.000747	0.000747	CcSEcCtD
Linezolid—Pneumonia—Doxorubicin—pancreatic cancer	0.000742	0.000742	CcSEcCtD
Linezolid—Pruritus—Fluorouracil—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Linezolid—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000739	0.000739	CcSEcCtD
Linezolid—Skin disorder—Docetaxel—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000732	0.000732	CcSEcCtD
Linezolid—Diarrhoea—Gemcitabine—pancreatic cancer	0.000727	0.000727	CcSEcCtD
Linezolid—Renal failure—Doxorubicin—pancreatic cancer	0.000726	0.000726	CcSEcCtD
Linezolid—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000724	0.000724	CcSEcCtD
Linezolid—Dizziness—Irinotecan—pancreatic cancer	0.000722	0.000722	CcSEcCtD
Linezolid—Haemoglobin—Epirubicin—pancreatic cancer	0.00072	0.00072	CcSEcCtD
Linezolid—Stomatitis—Doxorubicin—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Linezolid—Anorexia—Docetaxel—pancreatic cancer	0.000719	0.000719	CcSEcCtD
Linezolid—Haemorrhage—Epirubicin—pancreatic cancer	0.000716	0.000716	CcSEcCtD
Linezolid—Diarrhoea—Fluorouracil—pancreatic cancer	0.000715	0.000715	CcSEcCtD
Linezolid—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000713	0.000713	CcSEcCtD
Linezolid—Pharyngitis—Epirubicin—pancreatic cancer	0.000711	0.000711	CcSEcCtD
Linezolid—Vomiting—Irinotecan—pancreatic cancer	0.000694	0.000694	CcSEcCtD
Linezolid—Dizziness—Fluorouracil—pancreatic cancer	0.000691	0.000691	CcSEcCtD
Linezolid—Rash—Irinotecan—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Linezolid—Dermatitis—Irinotecan—pancreatic cancer	0.000687	0.000687	CcSEcCtD
Linezolid—Headache—Irinotecan—pancreatic cancer	0.000684	0.000684	CcSEcCtD
Linezolid—Insomnia—Docetaxel—pancreatic cancer	0.000682	0.000682	CcSEcCtD
Linezolid—Paraesthesia—Docetaxel—pancreatic cancer	0.000677	0.000677	CcSEcCtD
Linezolid—Erythema multiforme—Epirubicin—pancreatic cancer	0.000677	0.000677	CcSEcCtD
Linezolid—Vomiting—Gemcitabine—pancreatic cancer	0.000676	0.000676	CcSEcCtD
Linezolid—Dyspnoea—Docetaxel—pancreatic cancer	0.000672	0.000672	CcSEcCtD
Linezolid—Somnolence—Docetaxel—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Linezolid—Rash—Gemcitabine—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Linezolid—Dermatitis—Gemcitabine—pancreatic cancer	0.00067	0.00067	CcSEcCtD
Linezolid—Tinnitus—Epirubicin—pancreatic cancer	0.000668	0.000668	CcSEcCtD
Linezolid—Haemoglobin—Doxorubicin—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Linezolid—Headache—Gemcitabine—pancreatic cancer	0.000666	0.000666	CcSEcCtD
Linezolid—Vomiting—Fluorouracil—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Linezolid—Dyspepsia—Docetaxel—pancreatic cancer	0.000664	0.000664	CcSEcCtD
Linezolid—Haemorrhage—Doxorubicin—pancreatic cancer	0.000663	0.000663	CcSEcCtD
Linezolid—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Linezolid—Rash—Fluorouracil—pancreatic cancer	0.000659	0.000659	CcSEcCtD
Linezolid—Dermatitis—Fluorouracil—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Linezolid—Pharyngitis—Doxorubicin—pancreatic cancer	0.000658	0.000658	CcSEcCtD
Linezolid—Decreased appetite—Docetaxel—pancreatic cancer	0.000656	0.000656	CcSEcCtD
Linezolid—Headache—Fluorouracil—pancreatic cancer	0.000655	0.000655	CcSEcCtD
Linezolid—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000651	0.000651	CcSEcCtD
Linezolid—Fatigue—Docetaxel—pancreatic cancer	0.00065	0.00065	CcSEcCtD
Linezolid—Nausea—Irinotecan—pancreatic cancer	0.000648	0.000648	CcSEcCtD
Linezolid—Pain—Docetaxel—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Linezolid—Constipation—Docetaxel—pancreatic cancer	0.000645	0.000645	CcSEcCtD
Linezolid—Chills—Epirubicin—pancreatic cancer	0.000643	0.000643	CcSEcCtD
Linezolid—Nausea—Gemcitabine—pancreatic cancer	0.000631	0.000631	CcSEcCtD
Linezolid—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000627	0.000627	CcSEcCtD
Linezolid—Erythema—Epirubicin—pancreatic cancer	0.000623	0.000623	CcSEcCtD
Linezolid—Nausea—Fluorouracil—pancreatic cancer	0.000621	0.000621	CcSEcCtD
Linezolid—Tinnitus—Doxorubicin—pancreatic cancer	0.000618	0.000618	CcSEcCtD
Linezolid—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000617	0.000617	CcSEcCtD
Linezolid—Flatulence—Epirubicin—pancreatic cancer	0.000614	0.000614	CcSEcCtD
Linezolid—Dysgeusia—Epirubicin—pancreatic cancer	0.00061	0.00061	CcSEcCtD
Linezolid—Muscle spasms—Epirubicin—pancreatic cancer	0.000599	0.000599	CcSEcCtD
Linezolid—Abdominal pain—Docetaxel—pancreatic cancer	0.000596	0.000596	CcSEcCtD
Linezolid—Body temperature increased—Docetaxel—pancreatic cancer	0.000596	0.000596	CcSEcCtD
Linezolid—Chills—Doxorubicin—pancreatic cancer	0.000595	0.000595	CcSEcCtD
Linezolid—Vision blurred—Epirubicin—pancreatic cancer	0.000588	0.000588	CcSEcCtD
Linezolid—Erythema—Doxorubicin—pancreatic cancer	0.000577	0.000577	CcSEcCtD
Linezolid—Anaemia—Epirubicin—pancreatic cancer	0.000576	0.000576	CcSEcCtD
Linezolid—Flatulence—Doxorubicin—pancreatic cancer	0.000568	0.000568	CcSEcCtD
Linezolid—Dysgeusia—Doxorubicin—pancreatic cancer	0.000565	0.000565	CcSEcCtD
Linezolid—Vertigo—Epirubicin—pancreatic cancer	0.00056	0.00056	CcSEcCtD
Linezolid—Leukopenia—Epirubicin—pancreatic cancer	0.000558	0.000558	CcSEcCtD
Linezolid—Muscle spasms—Doxorubicin—pancreatic cancer	0.000555	0.000555	CcSEcCtD
Linezolid—Cough—Epirubicin—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Linezolid—Vision blurred—Doxorubicin—pancreatic cancer	0.000544	0.000544	CcSEcCtD
Linezolid—Asthenia—Docetaxel—pancreatic cancer	0.000541	0.000541	CcSEcCtD
Linezolid—Convulsion—Epirubicin—pancreatic cancer	0.00054	0.00054	CcSEcCtD
Linezolid—Hypertension—Epirubicin—pancreatic cancer	0.000538	0.000538	CcSEcCtD
Linezolid—Pruritus—Docetaxel—pancreatic cancer	0.000534	0.000534	CcSEcCtD
Linezolid—Anaemia—Doxorubicin—pancreatic cancer	0.000533	0.000533	CcSEcCtD
Linezolid—Dry mouth—Epirubicin—pancreatic cancer	0.000519	0.000519	CcSEcCtD
Linezolid—Vertigo—Doxorubicin—pancreatic cancer	0.000518	0.000518	CcSEcCtD
Linezolid—Leukopenia—Doxorubicin—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Linezolid—Diarrhoea—Docetaxel—pancreatic cancer	0.000516	0.000516	CcSEcCtD
Linezolid—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000509	0.000509	CcSEcCtD
Linezolid—Cough—Doxorubicin—pancreatic cancer	0.000503	0.000503	CcSEcCtD
Linezolid—Convulsion—Doxorubicin—pancreatic cancer	0.0005	0.0005	CcSEcCtD
Linezolid—Dizziness—Docetaxel—pancreatic cancer	0.000499	0.000499	CcSEcCtD
Linezolid—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Linezolid—Hypertension—Doxorubicin—pancreatic cancer	0.000498	0.000498	CcSEcCtD
Linezolid—Skin disorder—Epirubicin—pancreatic cancer	0.000494	0.000494	CcSEcCtD
Linezolid—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000492	0.000492	CcSEcCtD
Linezolid—Anorexia—Epirubicin—pancreatic cancer	0.000485	0.000485	CcSEcCtD
Linezolid—Dry mouth—Doxorubicin—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Linezolid—Vomiting—Docetaxel—pancreatic cancer	0.00048	0.00048	CcSEcCtD
Linezolid—Rash—Docetaxel—pancreatic cancer	0.000476	0.000476	CcSEcCtD
Linezolid—Dermatitis—Docetaxel—pancreatic cancer	0.000475	0.000475	CcSEcCtD
Linezolid—Headache—Docetaxel—pancreatic cancer	0.000473	0.000473	CcSEcCtD
Linezolid—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Linezolid—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Linezolid—Insomnia—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Linezolid—Skin disorder—Doxorubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Linezolid—Paraesthesia—Epirubicin—pancreatic cancer	0.000457	0.000457	CcSEcCtD
Linezolid—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000455	0.000455	CcSEcCtD
Linezolid—Dyspnoea—Epirubicin—pancreatic cancer	0.000454	0.000454	CcSEcCtD
Linezolid—Somnolence—Epirubicin—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Linezolid—Anorexia—Doxorubicin—pancreatic cancer	0.000449	0.000449	CcSEcCtD
Linezolid—Nausea—Docetaxel—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Linezolid—Dyspepsia—Epirubicin—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Linezolid—Decreased appetite—Epirubicin—pancreatic cancer	0.000442	0.000442	CcSEcCtD
Linezolid—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Linezolid—Fatigue—Epirubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Linezolid—Constipation—Epirubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Linezolid—Pain—Epirubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Linezolid—Insomnia—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Linezolid—Paraesthesia—Doxorubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Linezolid—Dyspnoea—Doxorubicin—pancreatic cancer	0.00042	0.00042	CcSEcCtD
Linezolid—Somnolence—Doxorubicin—pancreatic cancer	0.000419	0.000419	CcSEcCtD
Linezolid—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000416	0.000416	CcSEcCtD
Linezolid—Dyspepsia—Doxorubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Linezolid—Decreased appetite—Doxorubicin—pancreatic cancer	0.000409	0.000409	CcSEcCtD
Linezolid—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Linezolid—Fatigue—Doxorubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Linezolid—Urticaria—Epirubicin—pancreatic cancer	0.000404	0.000404	CcSEcCtD
Linezolid—Constipation—Doxorubicin—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Linezolid—Pain—Doxorubicin—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Linezolid—Abdominal pain—Epirubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Linezolid—Body temperature increased—Epirubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Linezolid—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000385	0.000385	CcSEcCtD
Linezolid—Urticaria—Doxorubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Linezolid—Body temperature increased—Doxorubicin—pancreatic cancer	0.000372	0.000372	CcSEcCtD
Linezolid—Abdominal pain—Doxorubicin—pancreatic cancer	0.000372	0.000372	CcSEcCtD
Linezolid—Asthenia—Epirubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Linezolid—Pruritus—Epirubicin—pancreatic cancer	0.00036	0.00036	CcSEcCtD
Linezolid—Diarrhoea—Epirubicin—pancreatic cancer	0.000348	0.000348	CcSEcCtD
Linezolid—Asthenia—Doxorubicin—pancreatic cancer	0.000338	0.000338	CcSEcCtD
Linezolid—Dizziness—Epirubicin—pancreatic cancer	0.000336	0.000336	CcSEcCtD
Linezolid—Pruritus—Doxorubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Linezolid—Vomiting—Epirubicin—pancreatic cancer	0.000323	0.000323	CcSEcCtD
Linezolid—Diarrhoea—Doxorubicin—pancreatic cancer	0.000322	0.000322	CcSEcCtD
Linezolid—Rash—Epirubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Linezolid—Dermatitis—Epirubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Linezolid—Headache—Epirubicin—pancreatic cancer	0.000319	0.000319	CcSEcCtD
Linezolid—Dizziness—Doxorubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Linezolid—Nausea—Epirubicin—pancreatic cancer	0.000302	0.000302	CcSEcCtD
Linezolid—Vomiting—Doxorubicin—pancreatic cancer	0.000299	0.000299	CcSEcCtD
Linezolid—Rash—Doxorubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Linezolid—Dermatitis—Doxorubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Linezolid—Headache—Doxorubicin—pancreatic cancer	0.000295	0.000295	CcSEcCtD
Linezolid—Nausea—Doxorubicin—pancreatic cancer	0.00028	0.00028	CcSEcCtD
